Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

doi:10.1111/j.1365-2141.2010.08326.x

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

British journal of haematology - 1 Nov 2010

Scandurra Marta, Mian Michael, Greiner Timothy C, Rancoita Paola M V, De Campos Cassio P, Chan Wing C, Vose Julie M, Chigrinova Ekaterina, Inghirami Giorgio, Chiappella Annalisa, Baldini Luca, Ponzoni Maurilio, Ferreri Andres J M, Franceschetti Silvia, Gaidano Gianluca, Montes-Moreno Santiago, Piris Miguel A, Facchetti Fabio, Tucci Alessandra, Nomdedeu Josep Fr, Lazure Thierry, Lambotte Olivier, Uccella Silvia, Pinotti Graziella, Pruneri Giancarlo, Martinelli Giovanni, Young Ken H, Tibiletti Maria Grazia, Rinaldi Andrea, Zucca Emanuele, Kwee Ivo, Bertoni Francesco

Abstract excerpt

Despite recent therapeutic improvements, the clinical course of diffuse large B-cell lymphoma (DLBCL) still differs considerably among patients. We conducted this retrospective multi-centre study to evaluate the impact of genomic aberrations detected using a high-density genome wide-single nucleo...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Murine-Derived

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclophosphamide

Share to Doxorubicin

Share to Epidemiologic Methods

Share to Lymphoma, Large B-Cell, Diffuse

Share to Prednisone

Share to Rituximab

Share to Vincristine

Source

Open in PubMed

Identifiers

PMID: 20813005
DOI: 10.1111/j.1365-2141.2010.08326.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20813005-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.PMID 20813005Read ↗

Characterization of genomic imbalances in diffuse large B-cell lymphoma by detailed SNP-chip analysis.Semantic proximity Read ↗

Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA studySemantic proximity Read ↗

Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphomaSemantic proximity Read ↗

Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma.Semantic proximity Read ↗

Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B‐cell lymphomasSemantic proximity Read ↗

Double-hit Signature with TP53 Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP.Semantic proximity Read ↗

Evidence-based review of genomic aberrations in diffuse large B cell lymphoma, not otherwise specified (DLBCL, NOS): Report from the cancer genomics consortium lymphoma working groupSemantic proximity Read ↗

Genomic profiling using array comparative genomic hybridization define distinct subtypes of diffuse large b-cell lymphoma: a review of the literatureSemantic proximity Read ↗

Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling.Semantic proximity Read ↗

Identified hidden genomic changes in mantle cell lymphoma using high-resolution single nucleotide polymorphism genomic array.Semantic proximity Read ↗

Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network reportSemantic proximity Read ↗

Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.